Teodora Djikić - Concepedia

Author

Teodora Djikić

University of Belgrade ORCID

Also Known As

Djikic, Teodora, Teodora Djikic, Teodora Djikic-Stojsic, Teodora Djikic‐Stojsic, Teodora Djikić

Publications

437

Citations

H-Index

Concepts

All Affiliations

University of Belgrade Kadir Has University Universitat de Barcelona Center for Research in Molecular Medicine and Chronic Diseases Marmara University

About

Teodora Djikić is an author at University of Belgrade specializing in tumor biology, chromatin, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Biomolecular Engineering	1	1	13
3	Cell Biology	1	1	13
4	Molecular Biology	1	1	13
5	Cell Signaling	1	1	13

Teodora Djikić

Publications

201

Citations

H-Index

Page 1

	Year	Citations
Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates Milica Radan, Teodora Djikić, Darija Obradović, European Journal of Pharmaceutical Sciences	2021	42
Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors Göknil Pelin Coşkun, Teodora Djikić, Taha Bartu Hayal, Molecules	2018	30
Synthesis and Screening of Human Monoamine Oxidase‐A Inhibitor Effect of New 2‐Pyrazoline and Hydrazone Derivatives Begüm Evranos‐Aksöz, İpek Baysal, Samiye Yabanoğlu‐Çiftçi, Archiv der Pharmazie	2015	25
Synthesis, anticancer activity, and molecular modeling of etodolac‐thioether derivatives as potent methionine aminopeptidase (type II) inhibitors Işıl Çoruh, Özge Çevik, Kemal Yelekçi, Archiv der Pharmazie	2018	25
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I<sub>2</sub> Receptor Ligands for Alzheimer’s Disease Sònia Abás, Sergio Rodríguez‐Arévalo, Andrea Bagán, Journal of Medicinal Chemistry	2020	23
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease Sergio Rodríguez‐Arévalo, Andrea Bagán, Christian Griñán‐Ferré, European Journal of Medicinal Chemistry	2021	18
<i>In silico</i> identification of novel 5-HT<sub>2A</sub> antagonists supported with ligand- and target-based drug design methodologies Milica Radan, Dušan Ružić, Mirjana Antonijević, Journal of Biomolecular Structure and Dynamics	2020	15
Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein Corentin Bon, Yang Si, Melanie Pernak, Molecules Histone ModificationsMixed-phenotype Acute LeukemiaEpigenetic ChangeMolecular BiologyCytostatic Inhibitor	2021	13
An Integrative <i>in silico</i> Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease Nemanja Djoković, Dušan Ružić, Teodora Djikić, Molecular Informatics	2021	10

Page 1